Meanwhile, we also observed that STM2457 enhanced the cytotoxic effect of venetoclax on drug-resistant AML cells by decreasing the protein levels of BCL2, MCL1 and MYC, while also inducing more apoptosis (Fig. 6I). Here, BCL2 is linked to acute myeloid leukemia.